APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Saliva Drug and Alcohol Testing

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Saliva Drug and Alcohol Testing Market Outlook and Growth Opportunities 2026

Report ID 17423479041 May 2026195 pages

Choose your research edition.

Industry ResearchSaliva Drug and Alcohol Testing Industry Research Report 2026145 pages · $2,950 USDIndustry Growth & TrendsGlobal Saliva Drug and Alcohol Testing Industry Growth and Trends Forecast to 2032122 pages · $3,450 USDMarket StructureGlobal Saliva Drug and Alcohol Testing Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Saliva Drug and Alcohol Testing Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Saliva Drug and Alcohol Testing Market Analysis and Forecast 2026-2032251 pages · $4,950 USD

Market perspective

The global Saliva Drug and Alcohol Testing market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Saliva Drug and Alcohol Testing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Saliva Drug and Alcohol Testing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Saliva Drug and Alcohol Testing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Saliva Drug and Alcohol Testing market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Saliva Drug and Alcohol Testing market include Abbott, OraSure Technologies, Premier Biotech, Alcolizer, CareHealth America, AlphaBiolabs, AlcoDigital, VeriCheck and Azova, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Saliva Drug and Alcohol Testing market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Saliva Drug and Alcohol Testing and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Saliva Drug and Alcohol Testing revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Saliva Drug and Alcohol Testing market.

Saliva Drug and Alcohol Testing Segment by Company

Abbott

OraSure Technologies

Premier Biotech

Alcolizer

CareHealth America

AlphaBiolabs

AlcoDigital

VeriCheck

Azova

Draeger

Securetec Detektions-Systeme

Quest Diagnostics

Oranoxis

Salimetrics

Neogen Corporation

UCP Biosciences

Lin-Zhi International

MEDACX

AccuBioTech

Wondfo Biotech

Assure Tech

Express Medicals

Crystal Health

KINNECT

AusHealth

Dorevitch Pathology

Labcorp

Eurofins

Concentra

Bellin Health

Randox

MediNat

Clinical Labs

MHE

Awanui Labs

David Barber Occupational Health

SYNLAB

Test Smartly Labs

Cansford Laboratories

Medigold Health

PAM Group

Drugwise

Safework Health

Humanomics

CannAmm

Micro-Distributing

Saliva Drug and Alcohol Testing Segment by Type

On-Site Screening Products

Lab Testing

Saliva Drug and Alcohol Testing Segment by Application

Criminal Justice Testing

Workplace Testing

Rehabilitation Therapy

Others

Saliva Drug and Alcohol Testing Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Saliva Drug and Alcohol Testing status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Saliva Drug and Alcohol Testing key companies, revenue, market share, and recent developments.

3. To split the Saliva Drug and Alcohol Testing breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Saliva Drug and Alcohol Testing market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Saliva Drug and Alcohol Testing significant trends, drivers, influence factors in global and regions.

6. To analyze Saliva Drug and Alcohol Testing competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Saliva Drug and Alcohol Testing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Saliva Drug and Alcohol Testing and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Saliva Drug and Alcohol Testing.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Saliva Drug and Alcohol Testing industry.

Chapter 3: Detailed analysis of Saliva Drug and Alcohol Testing company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Saliva Drug and Alcohol Testing in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Saliva Drug and Alcohol Testing in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Saliva Drug and Alcohol Testing Industry Trends Table 2. Saliva Drug and Alcohol Testing Industry Drivers Table 3. Saliva Drug and Alcohol Testing Industry Opportunities and Challenges Table 4. Saliva Drug and Alcohol Testing Industry Restraints Table 5. Global Saliva Drug and Alcohol Testing Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Saliva Drug and Alcohol Testing Revenue Share by Company (2021-2026) Table 7. Global Saliva Drug and Alcohol Testing Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Saliva Drug and Alcohol Testing Key Company Manufacturing Base & Headquarters Table 9. Global Saliva Drug and Alcohol Testing Company, Product Type & Application Table 10. Global Saliva Drug and Alcohol Testing Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Saliva Drug and Alcohol Testing by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of On-Site Screening Products Table 15. Significant Companies of Lab Testing Table 16. Global Saliva Drug and Alcohol Testing Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Saliva Drug and Alcohol Testing Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global Saliva Drug and Alcohol Testing Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global Saliva Drug and Alcohol Testing Sales Value Share by Type (2021-2026) Table 20. Global Saliva Drug and Alcohol Testing Sales Value Share by Type (2027-2032) Table 21. Significant Companies of Criminal Justice Testing Table 22. Significant Companies of Workplace Testing Table 23. Significant Companies of Rehabilitation Therapy Table 24. Significant Companies of Others Table 25. Global Saliva Drug and Alcohol Testing Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Saliva Drug and Alcohol Testing Sales Value by Application (2021-2026) & (US$ Million) Table 27. Global Saliva Drug and Alcohol Testing Sales Value by Application (2027-2032) & (US$ Million) Table 28. Global Saliva Drug and Alcohol Testing Sales Value Share by Application (2021-2026) Table 29. Global Saliva Drug and Alcohol Testing Sales Value Share by Application (2027-2032) Table 30. Global Saliva Drug and Alcohol Testing Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Saliva Drug and Alcohol Testing Sales Value by Region (2021-2026) & (US$ Million) Table 32. Global Saliva Drug and Alcohol Testing Sales Value Share by Region (2021-2026) Table 33. Global Saliva Drug and Alcohol Testing Sales Value by Region (2027-2032) & (US$ Million) Table 34. Global Saliva Drug and Alcohol Testing Sales Value Share by Region (2027-2032) Table 35. Global Saliva Drug and Alcohol Testing Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global Saliva Drug and Alcohol Testing Sales Value by Country (2021-2026) & (US$ Million) Table 37. Global Saliva Drug and Alcohol Testing Sales Value Market Share by Country (2021-2026) Table 38. Global Saliva Drug and Alcohol Testing Sales Value by Country (2027-2032) & (US$ Million) Table 39. Global Saliva Drug and Alcohol Testing Sales Value Market Share by Country (2027-2032) Table 40. Abbott Company Information Table 41. Abbott Business Overview Table 42. Abbott Saliva Drug and Alcohol Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 43. Abbott Saliva Drug and Alcohol Testing Product Portfolio Table 44. Abbott Recent Development Table 45. OraSure Technologies Company Information Table 46. OraSure Technologies Business Overview Table 47. OraSure Technologies Saliva Drug and Alcohol Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 48. OraSure Technologies Saliva Drug and Alcohol Testing Product Portfolio Table 49. OraSure Technologies Recent Development Table 50. Premier Biotech Company Information Table 51. Premier Biotech Business Overview Table 52. Premier Biotech Saliva Drug and Alcohol Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 53. Premier Biotech Saliva Drug and Alcohol Testing Product Portfolio Table 54. Premier Biotech Recent Development Table 55. Alcolizer Company Information Table 56. Alcolizer Business Overview Table 57. Alcolizer Saliva Drug and Alcohol Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 58. Alcolizer Saliva Drug and Alcohol Testing Product Portfolio Table 59. Alcolizer Recent Development Table 60. CareHealth America Company Information Table 61. CareHealth America Business Overview Table 62. CareHealth America Saliva Drug and Alcohol Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 63. CareHealth America Saliva Drug and Alcohol Testing Product Portfolio Table 64. CareHealth America Recent Development Table 65. AlphaBiolabs Company Information Table 66. AlphaBiolabs Business Overview Table 67. AlphaBiolabs Saliva Drug and Alcohol Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. AlphaBiolabs Saliva Drug and Alcohol Testing Product Portfolio Table 69. AlphaBiolabs Recent Development Table 70. AlcoDigital Company Information Table 71. AlcoDigital Business Overview Table 72. AlcoDigital Saliva Drug and Alcohol Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. AlcoDigital Saliva Drug and Alcohol Testing Product Portfolio Table 74. AlcoDigital Recent Development Table 75. VeriCheck Company Information Table 76. VeriCheck Business Overview Table 77. VeriCheck Saliva Drug and Alcohol Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. VeriCheck Saliva Drug and Alcohol Testing Product Portfolio Table 79. VeriCheck Recent Development Table 80. Azova Company Information Table 81. Azova Business Overview Table 82. Azova Saliva Drug and Alcohol Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. Azova Saliva Drug and Alcohol Testing Product Portfolio Table 84. Azova Recent Development Table 85. Draeger Company Information Table 86. Draeger Business Overview Table 87. Draeger Saliva Drug and Alcohol Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. Draeger Saliva Drug and Alcohol Testing Product Portfolio Table 89. Draeger Recent Development Table 90. Securetec Detektions-Systeme Company Information Table 91. Securetec Detektions-Systeme Business Overview Table 92. Securetec Detektions-Systeme Saliva Drug and Alcohol Testing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 93. Securetec Detektions-Systeme Saliva Drug and Alcohol Testing Product Portfolio Table 94. Securetec Detektions-Systeme Recent Development Table 95. Quest Diagnostics Company Information Table 96. Quest Diagnostics Business Overview Table 97. Quest Diagnostics Saliva Drug and Alcohol Testing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 98. Quest Diagnostics Saliva Drug and Alcohol Testing Product Portfolio Table 99. Quest Diagnostics Recent Development Table 100. Oranoxis Company Information Table 101. Oranoxis Business Overview Table 102. Oranoxis Saliva Drug and Alcohol Testing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 103. Oranoxis Saliva Drug and Alcohol Testing Product Portfolio Table 104. Oranoxis Recent Development Table 105. Salimetrics Company Information Table 106. Salimetrics Business Overview Table 107. Salimetrics Saliva Drug and Alcohol Testing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 108. Salimetrics Saliva Drug and Alcohol Testing Product Portfolio Table 109. Salimetrics Recent Development Table 110. Neogen Corporation Company Information Table 111. Neogen Corporation Business Overview Table 112. Neogen Corporation Saliva Drug and Alcohol Testing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 113. Neogen Corporation Saliva Drug and Alcohol Testing Product Portfolio Table 114. Neogen Corporation Recent Development Table 115. UCP Biosciences Company Information Table 116. UCP Biosciences Business Overview Table 117. UCP Biosciences Saliva Drug and Alcohol Testing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 118. UCP Biosciences Saliva Drug and Alcohol Testing Product Portfolio Table 119. UCP Biosciences Recent Development Table 120. Lin-Zhi International Company Information Table 121. Lin-Zhi International Business Overview Table 122. Lin-Zhi International Saliva Drug and Alcohol Testing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 123. Lin-Zhi International Saliva Drug and Alcohol Testing Product Portfolio Table 124. Lin-Zhi International Recent Development Table 125. MEDACX Company Information Table 126. MEDACX Business Overview Table 127. MEDACX Saliva Drug and Alcohol Testing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 128. MEDACX Saliva Drug and Alcohol Testing Product Portfolio Table 129. MEDACX Recent Development Table 130. AccuBioTech Company Information Table 131. AccuBioTech Business Overview Table 132. AccuBioTech Saliva Drug and Alcohol Testing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 133. AccuBioTech Saliva Drug and Alcohol Testing Product Portfolio Table 134. AccuBioTech Recent Development Table 135. Wondfo Biotech Company Information Table 136. Wondfo Biotech Business Overview Table 137. Wondfo Biotech Saliva Drug and Alcohol Testing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 138. Wondfo Biotech Saliva Drug and Alcohol Testing Product Portfolio Table 139. Wondfo Biotech Recent Development Table 140. Assure Tech Company Information Table 141. Assure Tech Business Overview Table 142. Assure Tech Saliva Drug and Alcohol Testing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 143. Assure Tech Saliva Drug and Alcohol Testing Product Portfolio Table 144. Assure Tech Recent Development Table 145. Express Medicals Company Information Table 146. Express Medicals Business Overview Table 147. Express Medicals Saliva Drug and Alcohol Testing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 148. Express Medicals Saliva Drug and Alcohol Testing Product Portfolio Table 149. Express Medicals Recent Development Table 150. Crystal Health Company Information Table 151. Crystal Health Business Overview Table 152. Crystal Health Saliva Drug and Alcohol Testing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 153. Crystal Health Saliva Drug and Alcohol Testing Product Portfolio Table 154. Crystal Health Recent Development Table 155. KINNECT Company Information Table 156. KINNECT Business Overview Table 157. KINNECT Saliva Drug and Alcohol Testing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 158. KINNECT Saliva Drug and Alcohol Testing Product Portfolio Table 159. KINNECT Recent Development Table 160. AusHealth Company Information Table 161. AusHealth Business Overview Table 162. AusHealth Saliva Drug and Alcohol Testing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 163. AusHealth Saliva Drug and Alcohol Testing Product Portfolio Table 164. AusHealth Recent Development Table 165. Dorevitch Pathology Company Information Table 166. Dorevitch Pathology Business Overview Table 167. Dorevitch Pathology Saliva Drug and Alcohol Testing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 168. Dorevitch Pathology Saliva Drug and Alcohol Testing Product Portfolio Table 169. Dorevitch Pathology Recent Development Table 170. Labcorp Company Information Table 171. Labcorp Business Overview Table 172. Labcorp Saliva Drug and Alcohol Testing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 173. Labcorp Saliva Drug and Alcohol Testing Product Portfolio Table 174. Labcorp Recent Development Table 175. Eurofins Company Information Table 176. Eurofins Business Overview Table 177. Eurofins Saliva Drug and Alcohol Testing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 178. Eurofins Saliva Drug and Alcohol Testing Product Portfolio Table 179. Eurofins Recent Development Table 180. Concentra Company Information Table 181. Concentra Business Overview Table 182. Concentra Saliva Drug and Alcohol Testing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 183. Concentra Saliva Drug and Alcohol Testing Product Portfolio Table 184. Concentra Recent Development Table 185. Bellin Health Company Information Table 186. Bellin Health Business Overview Table 187. Bellin Health Saliva Drug and Alcohol Testing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 188. Bellin Health Saliva Drug and Alcohol Testing Product Portfolio Table 189. Bellin Health Recent Development Table 190. Randox Company Information Table 191. Randox Business Overview Table 192. Randox Saliva Drug and Alcohol Testing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 193. Randox Saliva Drug and Alcohol Testing Product Portfolio Table 194. Randox Recent Development Table 195. MediNat Company Information Table 196. MediNat Business Overview Table 197. MediNat Saliva Drug and Alcohol Testing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 198. MediNat Saliva Drug and Alcohol Testing Product Portfolio Table 199. MediNat Recent Development Table 200. Clinical Labs Company Information Table 201. Clinical Labs Business Overview Table 202. Clinical Labs Saliva Drug and Alcohol Testing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 203. Clinical Labs Saliva Drug and Alcohol Testing Product Portfolio Table 204. Clinical Labs Recent Development Table 205. MHE Company Information Table 206. MHE Business Overview Table 207. MHE Saliva Drug and Alcohol Testing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 208. MHE Saliva Drug and Alcohol Testing Product Portfolio Table 209. MHE Recent Development Table 210. Awanui Labs Company Information Table 211. Awanui Labs Business Overview Table 212. Awanui Labs Saliva Drug and Alcohol Testing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 213. Awanui Labs Saliva Drug and Alcohol Testing Product Portfolio Table 214. Awanui Labs Recent Development Table 215. David Barber Occupational Health Company Information Table 216. David Barber Occupational Health Business Overview Table 217. David Barber Occupational Health Saliva Drug and Alcohol Testing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 218. David Barber Occupational Health Saliva Drug and Alcohol Testing Product Portfolio Table 219. David Barber Occupational Health Recent Development Table 220. SYNLAB Company Information Table 221. SYNLAB Business Overview Table 222. SYNLAB Saliva Drug and Alcohol Testing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 223. SYNLAB Saliva Drug and Alcohol Testing Product Portfolio Table 224. SYNLAB Recent Development Table 225. Test Smartly Labs Company Information Table 226. Test Smartly Labs Business Overview Table 227. Test Smartly Labs Saliva Drug and Alcohol Testing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 228. Test Smartly Labs Saliva Drug and Alcohol Testing Product Portfolio Table 229. Test Smartly Labs Recent Development Table 230. Cansford Laboratories Company Information Table 231. Cansford Laboratories Business Overview Table 232. Cansford Laboratories Saliva Drug and Alcohol Testing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 233. Cansford Laboratories Saliva Drug and Alcohol Testing Product Portfolio Table 234. Cansford Laboratories Recent Development Table 235. Medigold Health Company Information Table 236. Medigold Health Business Overview Table 237. Medigold Health Saliva Drug and Alcohol Testing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 238. Medigold Health Saliva Drug and Alcohol Testing Product Portfolio Table 239. Medigold Health Recent Development Table 240. Research Programs/Design for This Report Table 241. Authors List of This Report Table 242. Secondary Sources Table 243. Primary Sources List of Figures Figure 1. Saliva Drug and Alcohol Testing Product Image Figure 2. Global Saliva Drug and Alcohol Testing Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Saliva Drug and Alcohol Testing Market Size (2021-2032) & (US$ Million) Figure 4. Global Saliva Drug and Alcohol Testing Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. On-Site Screening Products Image Figure 8. Lab Testing Image Figure 9. Global Saliva Drug and Alcohol Testing Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global Saliva Drug and Alcohol Testing Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global Saliva Drug and Alcohol Testing Sales Value Share by Type (2021-2032) Figure 12. Criminal Justice Testing Image Figure 13. Workplace Testing Image Figure 14. Rehabilitation Therapy Image Figure 15. Others Image Figure 16. Global Saliva Drug and Alcohol Testing Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Saliva Drug and Alcohol Testing Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Saliva Drug and Alcohol Testing Sales Value Share by Application (2021-2032) Figure 19. Global Saliva Drug and Alcohol Testing Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 20. Global Saliva Drug and Alcohol Testing Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 21. North America Saliva Drug and Alcohol Testing Sales Value (2021-2032) & (US$ Million) Figure 22. North America Saliva Drug and Alcohol Testing Sales Value Share by Country (%), 2025 VS 2032 Figure 23. Europe Saliva Drug and Alcohol Testing Sales Value (2021-2032) & (US$ Million) Figure 24. Europe Saliva Drug and Alcohol Testing Sales Value Share by Country (%), 2025 VS 2032 Figure 25. Asia-Pacific Saliva Drug and Alcohol Testing Sales Value (2021-2032) & (US$ Million) Figure 26. Asia-Pacific Saliva Drug and Alcohol Testing Sales Value Share by Country (%), 2025 VS 2032 Figure 27. South America Saliva Drug and Alcohol Testing Sales Value (2021-2032) & (US$ Million) Figure 28. South America Saliva Drug and Alcohol Testing Sales Value Share by Country (%), 2025 VS 2032 Figure 29. Middle East & Africa Saliva Drug and Alcohol Testing Sales Value (2021-2032) & (US$ Million) Figure 30. Middle East & Africa Saliva Drug and Alcohol Testing Sales Value Share by Country (%), 2025 VS 2032 Figure 31. USA Saliva Drug and Alcohol Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 32. USA Saliva Drug and Alcohol Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 33. USA Saliva Drug and Alcohol Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 34. Canada Saliva Drug and Alcohol Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 35. Canada Saliva Drug and Alcohol Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 36. Canada Saliva Drug and Alcohol Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 37. Mexico Saliva Drug and Alcohol Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 38. Mexico Saliva Drug and Alcohol Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 39. Mexico Saliva Drug and Alcohol Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 40. Germany Saliva Drug and Alcohol Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. Germany Saliva Drug and Alcohol Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. Germany Saliva Drug and Alcohol Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. France Saliva Drug and Alcohol Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. France Saliva Drug and Alcohol Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. France Saliva Drug and Alcohol Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. U.K. Saliva Drug and Alcohol Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. U.K. Saliva Drug and Alcohol Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. U.K. Saliva Drug and Alcohol Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Italy Saliva Drug and Alcohol Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Italy Saliva Drug and Alcohol Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Italy Saliva Drug and Alcohol Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Spain Saliva Drug and Alcohol Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Spain Saliva Drug and Alcohol Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Spain Saliva Drug and Alcohol Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. Russia Saliva Drug and Alcohol Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. Russia Saliva Drug and Alcohol Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. Russia Saliva Drug and Alcohol Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Netherlands Saliva Drug and Alcohol Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Netherlands Saliva Drug and Alcohol Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Netherlands Saliva Drug and Alcohol Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Nordic Countries Saliva Drug and Alcohol Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Nordic Countries Saliva Drug and Alcohol Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Nordic Countries Saliva Drug and Alcohol Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. China Saliva Drug and Alcohol Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. China Saliva Drug and Alcohol Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. China Saliva Drug and Alcohol Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Japan Saliva Drug and Alcohol Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Japan Saliva Drug and Alcohol Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Japan Saliva Drug and Alcohol Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. South Korea Saliva Drug and Alcohol Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. South Korea Saliva Drug and Alcohol Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. South Korea Saliva Drug and Alcohol Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. India Saliva Drug and Alcohol Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. India Saliva Drug and Alcohol Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. India Saliva Drug and Alcohol Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Australia Saliva Drug and Alcohol Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Australia Saliva Drug and Alcohol Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Australia Saliva Drug and Alcohol Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Southeast Asia Saliva Drug and Alcohol Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Southeast Asia Saliva Drug and Alcohol Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Southeast Asia Saliva Drug and Alcohol Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. Brazil Saliva Drug and Alcohol Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. Brazil Saliva Drug and Alcohol Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. Brazil Saliva Drug and Alcohol Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Argentina Saliva Drug and Alcohol Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Argentina Saliva Drug and Alcohol Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Argentina Saliva Drug and Alcohol Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Chile Saliva Drug and Alcohol Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Chile Saliva Drug and Alcohol Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Chile Saliva Drug and Alcohol Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Colombia Saliva Drug and Alcohol Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Colombia Saliva Drug and Alcohol Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Colombia Saliva Drug and Alcohol Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Peru Saliva Drug and Alcohol Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Peru Saliva Drug and Alcohol Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Peru Saliva Drug and Alcohol Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Saudi Arabia Saliva Drug and Alcohol Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Saudi Arabia Saliva Drug and Alcohol Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Saudi Arabia Saliva Drug and Alcohol Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Israel Saliva Drug and Alcohol Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Israel Saliva Drug and Alcohol Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Israel Saliva Drug and Alcohol Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. UAE Saliva Drug and Alcohol Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. UAE Saliva Drug and Alcohol Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. UAE Saliva Drug and Alcohol Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Turkey Saliva Drug and Alcohol Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Turkey Saliva Drug and Alcohol Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Turkey Saliva Drug and Alcohol Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Iran Saliva Drug and Alcohol Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Iran Saliva Drug and Alcohol Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Iran Saliva Drug and Alcohol Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Egypt Saliva Drug and Alcohol Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Egypt Saliva Drug and Alcohol Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Egypt Saliva Drug and Alcohol Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Years Considered Figure 116. Research Process Figure 117. Key Executives Interviewed

Scope & coverage.

Types
  • On-Site Screening Products
  • Lab Testing
Applications
  • Criminal Justice Testing
  • Workplace Testing
  • Rehabilitation Therapy
  • Others
Companies covered
  • Abbott
  • OraSure Technologies
  • Premier Biotech
  • Alcolizer
  • CareHealth America
  • AlphaBiolabs
  • AlcoDigital
  • VeriCheck
  • Azova
  • Draeger
  • Securetec Detektions-Systeme
  • Quest Diagnostics
  • Oranoxis
  • Salimetrics
  • Neogen Corporation
  • UCP Biosciences
  • Lin-Zhi International
  • MEDACX
  • AccuBioTech
  • Wondfo Biotech
  • Assure Tech
  • Express Medicals
  • Crystal Health
  • KINNECT
  • AusHealth
  • Dorevitch Pathology
  • Labcorp
  • Eurofins
  • Concentra
  • Bellin Health
  • Randox
  • MediNat
  • Clinical Labs
  • MHE
  • Awanui Labs
  • David Barber Occupational Health
  • SYNLAB
  • Test Smartly Labs
  • Cansford Laboratories
  • Medigold Health
  • PAM Group
  • Drugwise
  • Safework Health
  • Humanomics
  • CannAmm
  • Micro-Distributing

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Saliva Drug and Alcohol Testing Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Saliva Drug and Alcohol Testing Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Saliva Drug and Alcohol Testing Market Dynamics
  1. 2.1 Saliva Drug and Alcohol Testing Industry Trends
  2. 2.2 Saliva Drug and Alcohol Testing Industry Drivers
  3. 2.3 Saliva Drug and Alcohol Testing Industry Opportunities and Challenges
  4. 2.4 Saliva Drug and Alcohol Testing Industry Restraints
3 Saliva Drug and Alcohol Testing Market by Company
  1. 3.1 Global Saliva Drug and Alcohol Testing Company Revenue Ranking in 2025
  2. 3.2 Global Saliva Drug and Alcohol Testing Revenue by Company (2021-2026)
  3. 3.3 Global Saliva Drug and Alcohol Testing Company Ranking (2024-2026)
  4. 3.4 Global Saliva Drug and Alcohol Testing Company Manufacturing Base and Headquarters
  5. 3.5 Global Saliva Drug and Alcohol Testing Company Product Type and Application
  6. 3.6 Global Saliva Drug and Alcohol Testing Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Saliva Drug and Alcohol Testing Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Saliva Drug and Alcohol Testing Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Saliva Drug and Alcohol Testing Market by Type
  1. 4.1 Saliva Drug and Alcohol Testing Type Introduction
  2. 4.1.1 On-Site Screening Products
  3. 4.1.2 Lab Testing
  4. 4.2 Global Saliva Drug and Alcohol Testing Sales Value by Type
  5. 4.2.1 Global Saliva Drug and Alcohol Testing Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Saliva Drug and Alcohol Testing Sales Value by Type (2021-2032)
  7. 4.2.3 Global Saliva Drug and Alcohol Testing Sales Value Share by Type (2021-2032)
5 Saliva Drug and Alcohol Testing Market by Application
  1. 5.1 Saliva Drug and Alcohol Testing Application Introduction
  2. 5.1.1 Criminal Justice Testing
  3. 5.1.2 Workplace Testing
  4. 5.1.3 Rehabilitation Therapy
  5. 5.1.4 Others
  6. 5.2 Global Saliva Drug and Alcohol Testing Sales Value by Application
  7. 5.2.1 Global Saliva Drug and Alcohol Testing Sales Value by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Saliva Drug and Alcohol Testing Sales Value by Application (2021-2032)
  9. 5.2.3 Global Saliva Drug and Alcohol Testing Sales Value Share by Application (2021-2032)
6 Saliva Drug and Alcohol Testing Regional Value Analysis
  1. 6.1 Global Saliva Drug and Alcohol Testing Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Saliva Drug and Alcohol Testing Sales Value by Region (2021-2032)
  3. 6.2.1 Global Saliva Drug and Alcohol Testing Sales Value by Region: 2021-2026
  4. 6.2.2 Global Saliva Drug and Alcohol Testing Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Saliva Drug and Alcohol Testing Sales Value (2021-2032)
  7. 6.3.2 North America Saliva Drug and Alcohol Testing Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Saliva Drug and Alcohol Testing Sales Value (2021-2032)
  10. 6.4.2 Europe Saliva Drug and Alcohol Testing Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Saliva Drug and Alcohol Testing Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Saliva Drug and Alcohol Testing Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Saliva Drug and Alcohol Testing Sales Value (2021-2032)
  16. 6.6.2 South America Saliva Drug and Alcohol Testing Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Saliva Drug and Alcohol Testing Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Saliva Drug and Alcohol Testing Sales Value Share by Country, 2025 VS 2032
7 Saliva Drug and Alcohol Testing Country-level Value Analysis
  1. 7.1 Global Saliva Drug and Alcohol Testing Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Saliva Drug and Alcohol Testing Sales Value by Country (2021-2032)
  3. 7.2.1 Global Saliva Drug and Alcohol Testing Sales Value by Country (2021-2026)
  4. 7.2.2 Global Saliva Drug and Alcohol Testing Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Saliva Drug and Alcohol Testing Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Saliva Drug and Alcohol Testing Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Saliva Drug and Alcohol Testing Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Saliva Drug and Alcohol Testing Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Saliva Drug and Alcohol Testing Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Saliva Drug and Alcohol Testing Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Saliva Drug and Alcohol Testing Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Saliva Drug and Alcohol Testing Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Saliva Drug and Alcohol Testing Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Saliva Drug and Alcohol Testing Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Saliva Drug and Alcohol Testing Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Saliva Drug and Alcohol Testing Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Saliva Drug and Alcohol Testing Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Saliva Drug and Alcohol Testing Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Saliva Drug and Alcohol Testing Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Saliva Drug and Alcohol Testing Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Saliva Drug and Alcohol Testing Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Saliva Drug and Alcohol Testing Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Saliva Drug and Alcohol Testing Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Saliva Drug and Alcohol Testing Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Saliva Drug and Alcohol Testing Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Saliva Drug and Alcohol Testing Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Saliva Drug and Alcohol Testing Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Saliva Drug and Alcohol Testing Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Saliva Drug and Alcohol Testing Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Saliva Drug and Alcohol Testing Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Saliva Drug and Alcohol Testing Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Saliva Drug and Alcohol Testing Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Saliva Drug and Alcohol Testing Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Saliva Drug and Alcohol Testing Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Saliva Drug and Alcohol Testing Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Saliva Drug and Alcohol Testing Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Saliva Drug and Alcohol Testing Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Saliva Drug and Alcohol Testing Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Saliva Drug and Alcohol Testing Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Saliva Drug and Alcohol Testing Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Saliva Drug and Alcohol Testing Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Saliva Drug and Alcohol Testing Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Saliva Drug and Alcohol Testing Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Saliva Drug and Alcohol Testing Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Saliva Drug and Alcohol Testing Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Saliva Drug and Alcohol Testing Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Saliva Drug and Alcohol Testing Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Saliva Drug and Alcohol Testing Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Saliva Drug and Alcohol Testing Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Saliva Drug and Alcohol Testing Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Saliva Drug and Alcohol Testing Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Saliva Drug and Alcohol Testing Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Saliva Drug and Alcohol Testing Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Saliva Drug and Alcohol Testing Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Saliva Drug and Alcohol Testing Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Saliva Drug and Alcohol Testing Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Saliva Drug and Alcohol Testing Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Saliva Drug and Alcohol Testing Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Saliva Drug and Alcohol Testing Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Saliva Drug and Alcohol Testing Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Saliva Drug and Alcohol Testing Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Saliva Drug and Alcohol Testing Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Saliva Drug and Alcohol Testing Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Saliva Drug and Alcohol Testing Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Saliva Drug and Alcohol Testing Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Saliva Drug and Alcohol Testing Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Saliva Drug and Alcohol Testing Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Saliva Drug and Alcohol Testing Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Saliva Drug and Alcohol Testing Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Saliva Drug and Alcohol Testing Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Saliva Drug and Alcohol Testing Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Saliva Drug and Alcohol Testing Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Saliva Drug and Alcohol Testing Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Saliva Drug and Alcohol Testing Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Saliva Drug and Alcohol Testing Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Saliva Drug and Alcohol Testing Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Saliva Drug and Alcohol Testing Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Saliva Drug and Alcohol Testing Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Saliva Drug and Alcohol Testing Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Saliva Drug and Alcohol Testing Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Saliva Drug and Alcohol Testing Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Saliva Drug and Alcohol Testing Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Saliva Drug and Alcohol Testing Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Saliva Drug and Alcohol Testing Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Saliva Drug and Alcohol Testing Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Saliva Drug and Alcohol Testing Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Saliva Drug and Alcohol Testing Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Saliva Drug and Alcohol Testing Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Abbott
  2. 8.1.1 Abbott Company Information
  3. 8.1.2 Abbott Business Overview
  4. 8.1.3 Abbott Saliva Drug and Alcohol Testing Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Abbott Saliva Drug and Alcohol Testing Product Portfolio
  6. 8.1.5 Abbott Recent Developments
  7. 8.2 OraSure Technologies
  8. 8.2.1 OraSure Technologies Company Information
  9. 8.2.2 OraSure Technologies Business Overview
  10. 8.2.3 OraSure Technologies Saliva Drug and Alcohol Testing Revenue and Gross Margin (2021-2026)
  11. 8.2.4 OraSure Technologies Saliva Drug and Alcohol Testing Product Portfolio
  12. 8.2.5 OraSure Technologies Recent Developments
  13. 8.3 Premier Biotech
  14. 8.3.1 Premier Biotech Company Information
  15. 8.3.2 Premier Biotech Business Overview
  16. 8.3.3 Premier Biotech Saliva Drug and Alcohol Testing Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Premier Biotech Saliva Drug and Alcohol Testing Product Portfolio
  18. 8.3.5 Premier Biotech Recent Developments
  19. 8.4 Alcolizer
  20. 8.4.1 Alcolizer Company Information
  21. 8.4.2 Alcolizer Business Overview
  22. 8.4.3 Alcolizer Saliva Drug and Alcohol Testing Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Alcolizer Saliva Drug and Alcohol Testing Product Portfolio
  24. 8.4.5 Alcolizer Recent Developments
  25. 8.5 CareHealth America
  26. 8.5.1 CareHealth America Company Information
  27. 8.5.2 CareHealth America Business Overview
  28. 8.5.3 CareHealth America Saliva Drug and Alcohol Testing Revenue and Gross Margin (2021-2026)
  29. 8.5.4 CareHealth America Saliva Drug and Alcohol Testing Product Portfolio
  30. 8.5.5 CareHealth America Recent Developments
  31. 8.6 AlphaBiolabs
  32. 8.6.1 AlphaBiolabs Company Information
  33. 8.6.2 AlphaBiolabs Business Overview
  34. 8.6.3 AlphaBiolabs Saliva Drug and Alcohol Testing Revenue and Gross Margin (2021-2026)
  35. 8.6.4 AlphaBiolabs Saliva Drug and Alcohol Testing Product Portfolio
  36. 8.6.5 AlphaBiolabs Recent Developments
  37. 8.7 AlcoDigital
  38. 8.7.1 AlcoDigital Company Information
  39. 8.7.2 AlcoDigital Business Overview
  40. 8.7.3 AlcoDigital Saliva Drug and Alcohol Testing Revenue and Gross Margin (2021-2026)
  41. 8.7.4 AlcoDigital Saliva Drug and Alcohol Testing Product Portfolio
  42. 8.7.5 AlcoDigital Recent Developments
  43. 8.8 VeriCheck
  44. 8.8.1 VeriCheck Company Information
  45. 8.8.2 VeriCheck Business Overview
  46. 8.8.3 VeriCheck Saliva Drug and Alcohol Testing Revenue and Gross Margin (2021-2026)
  47. 8.8.4 VeriCheck Saliva Drug and Alcohol Testing Product Portfolio
  48. 8.8.5 VeriCheck Recent Developments
  49. 8.9 Azova
  50. 8.9.1 Azova Company Information
  51. 8.9.2 Azova Business Overview
  52. 8.9.3 Azova Saliva Drug and Alcohol Testing Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Azova Saliva Drug and Alcohol Testing Product Portfolio
  54. 8.9.5 Azova Recent Developments
  55. 8.10 Draeger
  56. 8.10.1 Draeger Company Information
  57. 8.10.2 Draeger Business Overview
  58. 8.10.3 Draeger Saliva Drug and Alcohol Testing Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Draeger Saliva Drug and Alcohol Testing Product Portfolio
  60. 8.10.5 Draeger Recent Developments
  61. 8.11 Securetec Detektions-Systeme
  62. 8.11.1 Securetec Detektions-Systeme Company Information
  63. 8.11.2 Securetec Detektions-Systeme Business Overview
  64. 8.11.3 Securetec Detektions-Systeme Saliva Drug and Alcohol Testing Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Securetec Detektions-Systeme Saliva Drug and Alcohol Testing Product Portfolio
  66. 8.11.5 Securetec Detektions-Systeme Recent Developments
  67. 8.12 Quest Diagnostics
  68. 8.12.1 Quest Diagnostics Company Information
  69. 8.12.2 Quest Diagnostics Business Overview
  70. 8.12.3 Quest Diagnostics Saliva Drug and Alcohol Testing Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Quest Diagnostics Saliva Drug and Alcohol Testing Product Portfolio
  72. 8.12.5 Quest Diagnostics Recent Developments
  73. 8.13 Oranoxis
  74. 8.13.1 Oranoxis Company Information
  75. 8.13.2 Oranoxis Business Overview
  76. 8.13.3 Oranoxis Saliva Drug and Alcohol Testing Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Oranoxis Saliva Drug and Alcohol Testing Product Portfolio
  78. 8.13.5 Oranoxis Recent Developments
  79. 8.14 Salimetrics
  80. 8.14.1 Salimetrics Company Information
  81. 8.14.2 Salimetrics Business Overview
  82. 8.14.3 Salimetrics Saliva Drug and Alcohol Testing Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Salimetrics Saliva Drug and Alcohol Testing Product Portfolio
  84. 8.14.5 Salimetrics Recent Developments
  85. 8.15 Neogen Corporation
  86. 8.15.1 Neogen Corporation Company Information
  87. 8.15.2 Neogen Corporation Business Overview
  88. 8.15.3 Neogen Corporation Saliva Drug and Alcohol Testing Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Neogen Corporation Saliva Drug and Alcohol Testing Product Portfolio
  90. 8.15.5 Neogen Corporation Recent Developments
  91. 8.16 UCP Biosciences
  92. 8.16.1 UCP Biosciences Company Information
  93. 8.16.2 UCP Biosciences Business Overview
  94. 8.16.3 UCP Biosciences Saliva Drug and Alcohol Testing Revenue and Gross Margin (2021-2026)
  95. 8.16.4 UCP Biosciences Saliva Drug and Alcohol Testing Product Portfolio
  96. 8.16.5 UCP Biosciences Recent Developments
  97. 8.17 Lin-Zhi International
  98. 8.17.1 Lin-Zhi International Company Information
  99. 8.17.2 Lin-Zhi International Business Overview
  100. 8.17.3 Lin-Zhi International Saliva Drug and Alcohol Testing Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Lin-Zhi International Saliva Drug and Alcohol Testing Product Portfolio
  102. 8.17.5 Lin-Zhi International Recent Developments
  103. 8.18 MEDACX
  104. 8.18.1 MEDACX Company Information
  105. 8.18.2 MEDACX Business Overview
  106. 8.18.3 MEDACX Saliva Drug and Alcohol Testing Revenue and Gross Margin (2021-2026)
  107. 8.18.4 MEDACX Saliva Drug and Alcohol Testing Product Portfolio
  108. 8.18.5 MEDACX Recent Developments
  109. 8.19 AccuBioTech
  110. 8.19.1 AccuBioTech Company Information
  111. 8.19.2 AccuBioTech Business Overview
  112. 8.19.3 AccuBioTech Saliva Drug and Alcohol Testing Revenue and Gross Margin (2021-2026)
  113. 8.19.4 AccuBioTech Saliva Drug and Alcohol Testing Product Portfolio
  114. 8.19.5 AccuBioTech Recent Developments
  115. 8.20 Wondfo Biotech
  116. 8.20.1 Wondfo Biotech Company Information
  117. 8.20.2 Wondfo Biotech Business Overview
  118. 8.20.3 Wondfo Biotech Saliva Drug and Alcohol Testing Revenue and Gross Margin (2021-2026)
  119. 8.20.4 Wondfo Biotech Saliva Drug and Alcohol Testing Product Portfolio
  120. 8.20.5 Wondfo Biotech Recent Developments
  121. 8.21 Assure Tech
  122. 8.21.1 Assure Tech Company Information
  123. 8.21.2 Assure Tech Business Overview
  124. 8.21.3 Assure Tech Saliva Drug and Alcohol Testing Revenue and Gross Margin (2021-2026)
  125. 8.21.4 Assure Tech Saliva Drug and Alcohol Testing Product Portfolio
  126. 8.21.5 Assure Tech Recent Developments
  127. 8.22 Express Medicals
  128. 8.22.1 Express Medicals Company Information
  129. 8.22.2 Express Medicals Business Overview
  130. 8.22.3 Express Medicals Saliva Drug and Alcohol Testing Revenue and Gross Margin (2021-2026)
  131. 8.22.4 Express Medicals Saliva Drug and Alcohol Testing Product Portfolio
  132. 8.22.5 Express Medicals Recent Developments
  133. 8.23 Crystal Health
  134. 8.23.1 Crystal Health Company Information
  135. 8.23.2 Crystal Health Business Overview
  136. 8.23.3 Crystal Health Saliva Drug and Alcohol Testing Revenue and Gross Margin (2021-2026)
  137. 8.23.4 Crystal Health Saliva Drug and Alcohol Testing Product Portfolio
  138. 8.23.5 Crystal Health Recent Developments
  139. 8.24 KINNECT
  140. 8.24.1 KINNECT Company Information
  141. 8.24.2 KINNECT Business Overview
  142. 8.24.3 KINNECT Saliva Drug and Alcohol Testing Revenue and Gross Margin (2021-2026)
  143. 8.24.4 KINNECT Saliva Drug and Alcohol Testing Product Portfolio
  144. 8.24.5 KINNECT Recent Developments
  145. 8.25 AusHealth
  146. 8.25.1 AusHealth Company Information
  147. 8.25.2 AusHealth Business Overview
  148. 8.25.3 AusHealth Saliva Drug and Alcohol Testing Revenue and Gross Margin (2021-2026)
  149. 8.25.4 AusHealth Saliva Drug and Alcohol Testing Product Portfolio
  150. 8.25.5 AusHealth Recent Developments
  151. 8.26 Dorevitch Pathology
  152. 8.26.1 Dorevitch Pathology Company Information
  153. 8.26.2 Dorevitch Pathology Business Overview
  154. 8.26.3 Dorevitch Pathology Saliva Drug and Alcohol Testing Revenue and Gross Margin (2021-2026)
  155. 8.26.4 Dorevitch Pathology Saliva Drug and Alcohol Testing Product Portfolio
  156. 8.26.5 Dorevitch Pathology Recent Developments
  157. 8.27 Labcorp
  158. 8.27.1 Labcorp Company Information
  159. 8.27.2 Labcorp Business Overview
  160. 8.27.3 Labcorp Saliva Drug and Alcohol Testing Revenue and Gross Margin (2021-2026)
  161. 8.27.4 Labcorp Saliva Drug and Alcohol Testing Product Portfolio
  162. 8.27.5 Labcorp Recent Developments
  163. 8.28 Eurofins
  164. 8.28.1 Eurofins Company Information
  165. 8.28.2 Eurofins Business Overview
  166. 8.28.3 Eurofins Saliva Drug and Alcohol Testing Revenue and Gross Margin (2021-2026)
  167. 8.28.4 Eurofins Saliva Drug and Alcohol Testing Product Portfolio
  168. 8.28.5 Eurofins Recent Developments
  169. 8.29 Concentra
  170. 8.29.1 Concentra Company Information
  171. 8.29.2 Concentra Business Overview
  172. 8.29.3 Concentra Saliva Drug and Alcohol Testing Revenue and Gross Margin (2021-2026)
  173. 8.29.4 Concentra Saliva Drug and Alcohol Testing Product Portfolio
  174. 8.29.5 Concentra Recent Developments
  175. 8.30 Bellin Health
  176. 8.30.1 Bellin Health Company Information
  177. 8.30.2 Bellin Health Business Overview
  178. 8.30.3 Bellin Health Saliva Drug and Alcohol Testing Revenue and Gross Margin (2021-2026)
  179. 8.30.4 Bellin Health Saliva Drug and Alcohol Testing Product Portfolio
  180. 8.30.5 Bellin Health Recent Developments
  181. 8.31 Randox
  182. 8.31.1 Randox Company Information
  183. 8.31.2 Randox Business Overview
  184. 8.31.3 Randox Saliva Drug and Alcohol Testing Revenue and Gross Margin (2021-2026)
  185. 8.31.4 Randox Saliva Drug and Alcohol Testing Product Portfolio
  186. 8.31.5 Randox Recent Developments
  187. 8.32 MediNat
  188. 8.32.1 MediNat Company Information
  189. 8.32.2 MediNat Business Overview
  190. 8.32.3 MediNat Saliva Drug and Alcohol Testing Revenue and Gross Margin (2021-2026)
  191. 8.32.4 MediNat Saliva Drug and Alcohol Testing Product Portfolio
  192. 8.32.5 MediNat Recent Developments
  193. 8.33 Clinical Labs
  194. 8.33.1 Clinical Labs Company Information
  195. 8.33.2 Clinical Labs Business Overview
  196. 8.33.3 Clinical Labs Saliva Drug and Alcohol Testing Revenue and Gross Margin (2021-2026)
  197. 8.33.4 Clinical Labs Saliva Drug and Alcohol Testing Product Portfolio
  198. 8.33.5 Clinical Labs Recent Developments
  199. 8.34 MHE
  200. 8.34.1 MHE Company Information
  201. 8.34.2 MHE Business Overview
  202. 8.34.3 MHE Saliva Drug and Alcohol Testing Revenue and Gross Margin (2021-2026)
  203. 8.34.4 MHE Saliva Drug and Alcohol Testing Product Portfolio
  204. 8.34.5 MHE Recent Developments
  205. 8.35 Awanui Labs
  206. 8.35.1 Awanui Labs Company Information
  207. 8.35.2 Awanui Labs Business Overview
  208. 8.35.3 Awanui Labs Saliva Drug and Alcohol Testing Revenue and Gross Margin (2021-2026)
  209. 8.35.4 Awanui Labs Saliva Drug and Alcohol Testing Product Portfolio
  210. 8.35.5 Awanui Labs Recent Developments
  211. 8.36 David Barber Occupational Health
  212. 8.36.1 David Barber Occupational Health Company Information
  213. 8.36.2 David Barber Occupational Health Business Overview
  214. 8.36.3 David Barber Occupational Health Saliva Drug and Alcohol Testing Revenue and Gross Margin (2021-2026)
  215. 8.36.4 David Barber Occupational Health Saliva Drug and Alcohol Testing Product Portfolio
  216. 8.36.5 David Barber Occupational Health Recent Developments
  217. 8.37 SYNLAB
  218. 8.37.1 SYNLAB Company Information
  219. 8.37.2 SYNLAB Business Overview
  220. 8.37.3 SYNLAB Saliva Drug and Alcohol Testing Revenue and Gross Margin (2021-2026)
  221. 8.37.4 SYNLAB Saliva Drug and Alcohol Testing Product Portfolio
  222. 8.37.5 SYNLAB Recent Developments
  223. 8.38 Test Smartly Labs
  224. 8.38.1 Test Smartly Labs Company Information
  225. 8.38.2 Test Smartly Labs Business Overview
  226. 8.38.3 Test Smartly Labs Saliva Drug and Alcohol Testing Revenue and Gross Margin (2021-2026)
  227. 8.38.4 Test Smartly Labs Saliva Drug and Alcohol Testing Product Portfolio
  228. 8.38.5 Test Smartly Labs Recent Developments
  229. 8.39 Cansford Laboratories
  230. 8.39.1 Cansford Laboratories Company Information
  231. 8.39.2 Cansford Laboratories Business Overview
  232. 8.39.3 Cansford Laboratories Saliva Drug and Alcohol Testing Revenue and Gross Margin (2021-2026)
  233. 8.39.4 Cansford Laboratories Saliva Drug and Alcohol Testing Product Portfolio
  234. 8.39.5 Cansford Laboratories Recent Developments
  235. 8.40 Medigold Health
  236. 8.40.1 Medigold Health Company Information
  237. 8.40.2 Medigold Health Business Overview
  238. 8.40.3 Medigold Health Saliva Drug and Alcohol Testing Revenue and Gross Margin (2021-2026)
  239. 8.40.4 Medigold Health Saliva Drug and Alcohol Testing Product Portfolio
  240. 8.40.5 Medigold Health Recent Developments
  241. 8.41 PAM Group
  242. 8.42 Drugwise
  243. 8.43 Safework Health
  244. 8.44 Humanomics
  245. 8.45 CannAmm
  246. 8.46 Micro-Distributing
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst